In this study, Radiation Cystitis Modeling a Comparative Study of Bladder Fibrosis Radio-Sensitivity in C57BL6, C3H, and Balb/c Mice, researchers attributed the strength and uniqueness of their approach to the use of SARRP. This study was able to mimic the radiation treatment used in a clinical setting and minimize radiation toxicity or damage to surrounding tissues.
See the full details below, and article here.
Contact Us
Xstrahl presented The role of radiation technologists as a radiotherapy treatment at the 11th Congress of Radiological Technologists of R. N. Macedonia
Xstrahl, a global leader in the delivery of superficial radiation therapy devices and preclinical radiation research systems, will demonstrate Xstrahl 200, a modern orthovoltage radiotherapy solution for treating superficial lesions, skin cancers, and selective benign conditions at the 2024 American Society for Therapeutic Radiology and Oncology (ASTRO) Annual Meeting in Washington, DC Sept. 29-Oct 2, 2024, at booth #1937.
Xstrahl, the leader in preclinical radiation research systems, will demonstrate SmART-RAD at the 70th Annual Meeting of the Radiation Research Society (RRS) at the Westin La Paloma Resort & Spa, in Tucson, AZ, Sept. 15-18.
